Schrodinger Inc. (NASDAQ: SDGR) stock fell -0.51% on Friday to $33.03 against a previous-day closing price of $33.20. With 1.02 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.36 million shares. During the session, the Health Information Services company that operates in wider Healthcare sector, reached to the highest price of $33.33 whereas the lowest price it dropped to was $32.45. The 52-week range on SDGR shows that it touched its highest point at $59.24 and its lowest point at $15.85 during that stretch. It currently has a 1-year price target of $56.44. Beta for the stock currently stands at 1.29.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SDGR was down-trending over the past week, with a drop of -2.91%, but this was down by -4.79% over a month. Three-month performance dropped to -27.02% while six-month performance rose 24.03%. The stock gained 14.05% in the past year, while it has gained 76.73% so far this year. A look at the trailing 12-month EPS for SDGR yields 0.86 with Next year EPS estimates of -1.78. For the next quarter, that number is -0.73. This implies an EPS growth rate of -47.40% for this year and -337.30% for next year. EPS is expected to decline by -4.30% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -49.20%.
Float and Shares Shorts:
At present, 71.64 million SDGR shares are outstanding with a float of 49.59 million shares on hand for trading. On Aug 30, 2023, short shares totaled 7.06 million, which was 9.83% higher than short shares on Jul 30, 2023. In addition to Dr. Ramy Farid Ph.D. as the firm’s CEO, Pres & Director, Dr. Richard A. Friesner Ph.D. serves as its Co-Founder, Scientific Advisory Chairman and Director.
Institutional Ownership:
Through their ownership of 83.96% of SDGR’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 50.66% of SDGR, in contrast to 40.96% held by mutual funds. Shares owned by individuals account for 23.92%. As the largest shareholder in SDGR with 12.47% of the stake, BlackRock Fund Advisors holds 7,819,738 shares worth 7,819,738. A second-largest stockholder of SDGR, Bill & Melinda Gates Foundation T, holds 6,981,664 shares, controlling over 11.13% of the firm’s shares. The Vanguard Group, Inc. is the third largest shareholder in SDGR, holding 6,508,589 shares or 10.38% stake. With a 6.03% stake in SDGR, the iShares Core S&P Small Cap ETF is the largest stakeholder. A total of 3,780,332 shares are owned by the mutual fund manager. The ARK Genomic Revolution ETF, which owns about 4.82% of SDGR stock, is the second-largest Mutual Fund holder. It holds 3,020,580 shares valued at 111.43 million. Vanguard Total Stock Market ETF holds 3.14% of the stake in SDGR, owning 1,967,863 shares worth 72.59 million.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2023, SDGR reported revenue of $38.47M and operating income of -$43.47M. The EBITDA in the recently reported quarter was -$26.65M and diluted EPS was -$0.67.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for SDGR since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With SDGR analysts setting a high price target of $80.00 and a low target of $31.00, the average target price over the next 12 months is $56.44. Based on these targets, SDGR could surge 142.2% to reach the target high and fall by -6.15% to reach the target low. Reaching the average price target will result in a growth of 70.87% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded SDGR stock several times over the past three months with 2 Buys and 2 Sells. In these transactions, 27,040 shares were bought while 22,040 shares were sold. The number of buy transactions has increased to 21 while that of sell transactions has risen to 8 over the past year. The total number of shares bought during that period was 241,041 while 161,736 shares were sold.
